You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Exercise Disclosure
Goodman Noah · SEC Form 4 · Filed Jun 25, 2026
Exercise
Calculated transaction value
$0
Goodman Noah Chief Business Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jun 25, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed same day
KYMR daily price context
Close on/before transaction
$116.46
Jun 25, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-283139
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$675.25K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Exercise | Jun 25, 2026 | $105.25K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 25, 2026 | $272.5K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 25, 2026 | $297.5K |
| Kymera Therapeutics, Inc. KYMR Current | Exercise | Jun 25, 2026 | $0 |